Screening children for type 1: what the UK ELSA results found
The UK ELSA study reported that screening 17,283 children for type 1 antibodies works in practice and could cut dangerous emergency DKA diagnoses.
Being diagnosed with type 1 out of the blue, in a frightening hospital emergency, is still how it happens for far too many children. A large UK study called ELSA set out to change that by screening 17,283 children for the early immune signs of type 1. In January 2026 it reported that this works and could prevent many of those emergency diagnoses. As things stand, more than a quarter of children are only found to have type 1 once they are already ill with DKA (diabetic ketoacidosis, when a lack of insulin makes the blood acidic). Screening can catch the process years earlier, and while it is not yet a national NHS programme, it is the evidence that could lead to one.
- ELSA was a UK study that screened 17,283 children for the immune markers (antibodies) that appear before type 1 symptoms start.
- It found that screening is workable in practice and could cut the number of children diagnosed in a DKA emergency.
- Currently over a quarter of children are not diagnosed until they are already in DKA, a dangerous condition needing urgent hospital care.
- Finding type 1 early means it can be watched and prepared for, so diagnosis is a planned appointment rather than an ambulance.
- This is a study, not yet a national programme, so routine screening is not offered everywhere, though family screening can be looked into.
What ELSA actually looked at
ELSA offered a blood test to thousands of children to look for autoantibodies, the immune markers that show the body has started attacking its own insulin-making cells. These markers can be present years before a child feels unwell. Having them does not mean diabetes tomorrow; it means a raised risk, and it lets doctors know a child is on the path so they can keep an eye out.
The headline finding was that this works. Screening 17,283 children was practical, families took part, and it identified children in the earlier stages, some already close to needing insulin. The study team argue it could prevent a large share of the emergency diagnoses that happen now, which is where the real value lies for parents.
Why catching it early is such a big deal
The reason this matters is DKA. As things stand, more than a quarter of children are not diagnosed until they are in diabetic ketoacidosis, when the lack of insulin has made the blood acidic and the child is seriously ill. It is frightening, it can be life-threatening, and it is often a family’s first, brutal introduction to type 1. Knowing a child is at high risk means the warning signs are recognised early and insulin is started before that crisis, so diagnosis can happen calmly in a clinic.
Early knowledge can also open other doors, such as closer monitoring and, for some, access to treatments that aim to delay the full onset. For now, though, the practical picture in the UK is that screening is not yet routine. It is offered through studies and, in some cases, to close relatives of someone who already has type 1, whose own risk is higher. If that describes your family, it is a fair thing to raise with your team.
Worth knowing for families
Questions that make an appointment useful
When it's urgent
If a child is very thirsty, weeing a lot (including new bedwetting), losing weight or worn out, get them a same-day appointment with a GP or call NHS 111, and ask specifically about type 1 diabetes. If they are also being sick, drowsy or hard to wake, breathing heavily or fast, in tummy pain, or their breath smells fruity, this can be DKA, a life-threatening emergency: call 999 or go to A and E straight away. Do not wait to see if it passes, and do not let any home test delay the call.